A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.
Identifieur interne : 000164 ( PubMed/Corpus ); précédent : 000163; suivant : 000165A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.
Auteurs : P. Karaca-Mandic ; A T Hirsch ; S G Rockson ; S H RidnerSource :
- The British journal of dermatology [ 1365-2133 ] ; 2017.
Abstract
Patients with lymphedema suffer lifelong swelling and recurrent cellulitis despite use of complete decongestive therapy. Pneumatic compression devices (PCDs), including non-programmable and programmable devices that meet individual patient needs, support long term self-care in the home. Yet, to date, no direct comparison of their relative benefits has been available.
DOI: 10.1111/bjd.15699
PubMed: 28573790
Links to Exploration step
pubmed:28573790Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.</title><author><name sortKey="Karaca Mandic, P" sort="Karaca Mandic, P" uniqKey="Karaca Mandic P" first="P" last="Karaca-Mandic">P. Karaca-Mandic</name><affiliation><nlm:affiliation>Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.</nlm:affiliation></affiliation></author><author><name sortKey="Hirsch, A T" sort="Hirsch, A T" uniqKey="Hirsch A" first="A T" last="Hirsch">A T Hirsch</name><affiliation><nlm:affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis.</nlm:affiliation></affiliation></author><author><name sortKey="Rockson, S G" sort="Rockson, S G" uniqKey="Rockson S" first="S G" last="Rockson">S G Rockson</name><affiliation><nlm:affiliation>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California.</nlm:affiliation></affiliation></author><author><name sortKey="Ridner, S H" sort="Ridner, S H" uniqKey="Ridner S" first="S H" last="Ridner">S H Ridner</name><affiliation><nlm:affiliation>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville, Tennessee.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28573790</idno><idno type="pmid">28573790</idno><idno type="doi">10.1111/bjd.15699</idno><idno type="wicri:Area/PubMed/Corpus">000164</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000164</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.</title><author><name sortKey="Karaca Mandic, P" sort="Karaca Mandic, P" uniqKey="Karaca Mandic P" first="P" last="Karaca-Mandic">P. Karaca-Mandic</name><affiliation><nlm:affiliation>Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.</nlm:affiliation></affiliation></author><author><name sortKey="Hirsch, A T" sort="Hirsch, A T" uniqKey="Hirsch A" first="A T" last="Hirsch">A T Hirsch</name><affiliation><nlm:affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis.</nlm:affiliation></affiliation></author><author><name sortKey="Rockson, S G" sort="Rockson, S G" uniqKey="Rockson S" first="S G" last="Rockson">S G Rockson</name><affiliation><nlm:affiliation>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California.</nlm:affiliation></affiliation></author><author><name sortKey="Ridner, S H" sort="Ridner, S H" uniqKey="Ridner S" first="S H" last="Ridner">S H Ridner</name><affiliation><nlm:affiliation>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville, Tennessee.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The British journal of dermatology</title><idno type="eISSN">1365-2133</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Patients with lymphedema suffer lifelong swelling and recurrent cellulitis despite use of complete decongestive therapy. Pneumatic compression devices (PCDs), including non-programmable and programmable devices that meet individual patient needs, support long term self-care in the home. Yet, to date, no direct comparison of their relative benefits has been available.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">28573790</PMID><DateCreated><Year>2017</Year><Month>06</Month><Day>02</Day></DateCreated><DateRevised><Year>2017</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2133</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>The British journal of dermatology</Title><ISOAbbreviation>Br. J. Dermatol.</ISOAbbreviation></Journal><ArticleTitle>A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/bjd.15699</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with lymphedema suffer lifelong swelling and recurrent cellulitis despite use of complete decongestive therapy. Pneumatic compression devices (PCDs), including non-programmable and programmable devices that meet individual patient needs, support long term self-care in the home. Yet, to date, no direct comparison of their relative benefits has been available.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Patients who acquired either a non-programmable device (NP-PCD) or a dynamic pressure programmable device (P-PCD; Flexitouch(®) ) were evaluated to compare associated clinical and health utilization outcomes pre/post-device acquisition.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective analysis of de-identified administrative claims from 2007 through 2013 of a large United States insurer. The study populations were defined pre hoc as distinct cancer- and non-cancer-related lymphedema cohorts. Outcome variables included rates of lymphedema-related cellulitis, manual therapy use, outpatient services, and inpatient hospitalizations. Multivariate regression analysis was performed to: (1) compare outcomes for the 12 months pre- and post-device acquisition and (2) compare these two device types for their treatment-associated benefits.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The sample consisted of 1,013 NP-PCD and 718 P-PCD recipients. Compared with the NP-PCD group, P-PCD patients' baseline cellulitis rate was higher, while their post-device cellulitis rate was lower. In the cancer cohort, the NP-PCD group had a 53% reduction in episodes of cellulitis (from 17.9% to 8.5%), compared to a greater 79% reduction in the P-PCD group (from 23.7% to 5.0%) (p<0.001). In the non-cancer cohort, the P-PCD group also experienced a larger 76% decline (from 31.7% to 7.4%) vs. 54% decline (from 22.9% to 10.6%) in cellulitis rates (p=0.003). Outpatient service use reduced in both device groups, with greater reductions observed in P-PCD group. Both device groups experienced reductions in manual therapy use. Inpatient hospitalizations were largely stable with reductions observed only in the non-cancer cohort of the P-PCD group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">P-PCD receipt was associated with superior lymphedema-related health outcomes and reductions in cellulitis. This article is protected by copyright. All rights reserved.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karaca-Mandic</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirsch</LastName><ForeName>A T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rockson</LastName><ForeName>S G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridner</LastName><ForeName>S H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Vanderbilt University School of Nursing, Nashville, Tennessee (Ridner); Vanderbilt Ingram Cancer Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Dermatol</MedlineTA><NlmUniqueID>0004041</NlmUniqueID><ISSNLinking>0007-0963</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28573790</ArticleId><ArticleId IdType="doi">10.1111/bjd.15699</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000164 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000164 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28573790
|texte= A Comparison of Programmable and Non-Programmable Compression Devices for Treatment of Lymphedema Using an Administrative Health Outcomes Dataset.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28573790" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |